UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 168

Sortiert nach

Ghrelin Stimulates Gastric Emptying and Hunger in Normal-Weight Humans

The journal of clinical endocrinology and metabolism, 2006-09, Vol.91 (9), p.3296-3302

2006

Link zum Volltext

Verfügbarkeit prüfen

Traitement de substitution par l’hormone de croissance (GH) chez les patients âgés de ≥ 60 ans présentant un déficit en GH chez l’adulte (AGHD) : données de NordiNet® IOS et du programme ANSWER

Annales d'endocrinologie, 2023-02, Vol.84 (1), p.91-91

2023

Link zum Volltext

Verfügbarkeit prüfen

Pituitary function within the first year after traumatic brain injury or subarachnoid haemorrhage

Journal of endocrinological investigation, 2017-02, Vol.40 (2), p.193-205

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of pituitary dysfunction on cognitive and global outcome after traumatic brain injury and aneurysmal subarachnoid haemorrhage

Journal of rehabilitation medicine, 2019-04, Vol.51 (4), p.264-272

2019

Link zum Volltext

Verfügbarkeit prüfen

Influence of growth hormone on circulating fibroblast growth factor 21 levels in humans

Journal of internal medicine, 2013-09, Vol.274 (3), p.227-232

2013

Link zum Volltext

Verfügbarkeit prüfen

Deaths Among Adult Patients With Hypopituitarism: Hypocortisolism During Acute Stress, and De Novo Malignant Brain Tumors Contribute to an Increased Mortality

The journal of clinical endocrinology and metabolism, 2013-04, Vol.98 (4), p.1466-1475

2013

Link zum Volltext

Verfügbarkeit prüfen

Increased Mortality Persists after Treatment of Cushing’s Disease: A Matched Nationwide Cohort Study

Journal of the Endocrine Society, 2022-06, Vol.6 (6), p.bvac045-bvac045

2022

Link zum Volltext

Verfügbarkeit prüfen

Psychotropic Drugs in Patients with Cushing’s Disease Before Diagnosis and at Long-Term Follow-Up: A Nationwide Study

The journal of clinical endocrinology and metabolism, 2021, Vol.106 (6), p.1750-1760

2021

Link zum Volltext

Verfügbarkeit prüfen

Establishing a valid cohort of patients with acromegaly by combining the National Patient Register with the Swedish Pituitary Register

Journal of endocrinological investigation, 2023, Vol.47 (4), p.995-1003

2023

Link zum Volltext

Verfügbarkeit prüfen

Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery

Neurosurgery, 2001-08, Vol.49 (2), p.284-292

2001

Link zum Volltext

Verfügbarkeit prüfen

Contribution of gluconeogenesis and glycogenolysis to hepatic glucose production in acromegaly before and after pituitary microsurgery

Hormone and metabolic research, 2008-07, Vol.40 (7), p.498

2008

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcomes of patients with acromegaly: a report from the Swedish Pituitary Register

European journal of endocrinology, 2022, Vol.186 (3), p.329

2022

Link zum Volltext

Verfügbarkeit prüfen

Salivary cortisol and cortisone in diagnosis of Cushing's syndrome - a comparison of six different analytical methods

Clinical chemistry and laboratory medicine, 2023, Vol.61 (10), p.1780

2023

Link zum Volltext

Verfügbarkeit prüfen

Natural history and surgical outcome of Rathke's cleft cysts—A study from the Swedish Pituitary Registry

Clinical endocrinology (Oxford), 2022-01, Vol.96 (1), p.54-61

2022

Link zum Volltext

Verfügbarkeit prüfen

The transition from pediatric to adult care in individuals with Prader-Willi syndrome

Endocrine Connections, 2023-01, Vol.12 (1), p.1-11

2023

Link zum Volltext

Verfügbarkeit prüfen

OR7-1: A reversible albumin-binding GH derivative possesses a promising once-weekly treatment profile and is well tolerated in adult subjects with growth hormone deficiency

Growth hormone & IGF research, 2014-10, Vol.24, p.S18-S18

2014

Link zum Volltext

Verfügbarkeit prüfen

OR03-5 A phase 2, multicenter, multiple-dose, open-label, parallel-group, active controlled, safety, tolerability, pharmacokinetic and pharmacodynamic study of ACP-001 in adult patients with Growth Hormone Deficiency (AGHD)

Growth hormone & IGF research, 2012-10, Vol.22, p.S8-S9

2012

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide

The journal of clinical endocrinology and metabolism, 2015-04, Vol.100 (4), p.1689-1698

2015

Link zum Volltext

Verfügbarkeit prüfen

Reference intervals of salivary cortisol and cortisone and their diagnostic accuracy in Cushing's syndrome

European journal of endocrinology, 2020-06, Vol.182 (6), p.569

2020

Link zum Volltext

Verfügbarkeit prüfen

PO2-5: Severe headache relieved by short-acting somatostatin analogue in a patient with Acromegaly resistant to longacting somatostatin analogues

Growth hormone & IGF research, 2014-10, Vol.24, p.S40-S40

Hoybye, C

2014

Link zum Volltext

Verfügbarkeit prüfen

Effects of Growth Hormone Treatment on Sleep-Related Parameters in Adults With Prader-Willi Syndrome

The journal of clinical endocrinology and metabolism, 2021-09, Vol.106 (9), p.e3634-e3643

2021

Link zum Volltext

Verfügbarkeit prüfen

Reduced CV risk with long-term GH replacement in AGHD: data from two large observational studies

Endocrine Connections, 2023-01, Vol.12 (1), p.1-13

2023

Link zum Volltext

Verfügbarkeit prüfen

P03-30 Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome

Growth hormone & IGF research, 2012-10, Vol.22, p.S82-S82

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparing treatment with daily and long-acting growth hormone formulations in adults with growth hormone deficiency: Challenging issues, benefits, and risks

Best Practice & Research Clinical Endocrinology & Metabolism, 2023-12, Vol.37 (6), p.101788-101788, Article 101788

Hoybye, C

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 168

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(163)
Mit Volltextzugriff
(142)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(124)
Life Sciences & Biomedicine
(123)
Medicin Och Hälsovetenskap
(121)
Humans
(98)
Endocrinology & Metabolism
(94)
Female
(77)
Adult
(76)
Male
(70)
Middle Aged
(50)
Aged
(32)
Clinical Medicine
(30)
Endocrinology
(30)
Human Growth Hormone - Therapeutic Use
(26)
Medicine
(25)
Patients
(25)
Adults
(24)
Prader-Willi Syndrome
(24)
Adolescent
(23)
Klinisk Medicin
(23)
Endokrinologi Och Diabetes
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ghrelin Stimulates Gastric Emptying and Hunger in Normal-Weight Humans

Traitement de substitution par l’hormone de croissance (GH) chez les patients âgés de ≥ 60 ans présentant un déficit en GH chez l’adulte (AGHD) : données de NordiNet® IOS et du programme ANSWER

Pituitary function within the first year after traumatic brain injury or subarachnoid haemorrhage

Impact of pituitary dysfunction on cognitive and global outcome after traumatic brain injury and aneurysmal subarachnoid haemorrhage

Influence of growth hormone on circulating fibroblast growth factor 21 levels in humans

Deaths Among Adult Patients With Hypopituitarism: Hypocortisolism During Acute Stress, and De Novo Malignant Brain Tumors Contribute to an Increased Mortality

Increased Mortality Persists after Treatment of Cushing’s Disease: A Matched Nationwide Cohort Study

Psychotropic Drugs in Patients with Cushing’s Disease Before Diagnosis and at Long-Term Follow-Up: A Nationwide Study

Establishing a valid cohort of patients with acromegaly by combining the National Patient Register with the Swedish Pituitary Register

Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery

Contribution of gluconeogenesis and glycogenolysis to hepatic glucose production in acromegaly before and after pituitary microsurgery

Long-term outcomes of patients with acromegaly: a report from the Swedish Pituitary Register

Salivary cortisol and cortisone in diagnosis of Cushing's syndrome - a comparison of six different analytical methods

Natural history and surgical outcome of Rathke's cleft cysts—A study from the Swedish Pituitary Registry

The transition from pediatric to adult care in individuals with Prader-Willi syndrome

OR7-1: A reversible albumin-binding GH derivative possesses a promising once-weekly treatment profile and is well tolerated in adult subjects with growth hormone deficiency

OR03-5 A phase 2, multicenter, multiple-dose, open-label, parallel-group, active controlled, safety, tolerability, pharmacokinetic and pharmacodynamic study of ACP-001 in adult patients with Growth Hormone Deficiency (AGHD)

Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide

Reference intervals of salivary cortisol and cortisone and their diagnostic accuracy in Cushing's syndrome

PO2-5: Severe headache relieved by short-acting somatostatin analogue in a patient with Acromegaly resistant to longacting somatostatin analogues

Effects of Growth Hormone Treatment on Sleep-Related Parameters in Adults With Prader-Willi Syndrome

Reduced CV risk with long-term GH replacement in AGHD: data from two large observational studies

P03-30 Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome

Prevalence of Nelson’s syndrome after bilateral adrenalectomy in patients with cushing’s disease: a systematic review and meta-analysis

Comparing treatment with daily and long-acting growth hormone formulations in adults with growth hormone deficiency: Challenging issues, benefits, and risks

Suchergebnisse filtern